Provided by Tiger Fintech (Singapore) Pte. Ltd.

Warrior Met Coal LLC

47.30
-0.0100-0.02%
Pre-market: 46.93-0.3700-0.78%06:58 EDT
Volume:498.39K
Turnover:23.52M
Market Cap:2.49B
PE:23.49
High:47.50
Open:46.93
Low:46.43
Close:47.31
Loading ...

Can-Fite Has Raised $175 Million in Total to Date for the Development of Namodenoson and Piclidenoson, Advancing into Pivotal Phase 3 Trials in Liver Cancer and Psoriasis

GlobeNewswire
·
Yesterday

Stock Track | Warrior Met Coal Surges 5.06% Despite Mixed Q1 Results, Investors Focus on Revenue Beat and Growth Forecast

Stock Track
·
02 May

Warrior Met Coal First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
02 May

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

GlobeNewswire
·
02 May

Stock Track | Warrior Met Coal Plummets 5.05% Following Q1 Earnings Miss and Weak Outlook

Stock Track
·
01 May

Q1 2025 Warrior Met Coal Inc Earnings Call

Thomson Reuters StreetEvents
·
01 May

Warrior Met Coal Inc (HCC) Q1 2025 Earnings Call Highlights: Navigating Market Challenges with ...

GuruFocus.com
·
01 May

Warrior Met Coal (HCC) Reports Q1 Loss, Tops Revenue Estimates

Zacks
·
01 May

Warrior Met Coal Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
01 May

Warrior Met Coal Q1 Adj. EPS $(0.16) Misses $0.01 Estimate, Sales $299.94M Beat $284.57M Estimate

Benzinga
·
01 May

Warrior Met Coal Inc - Full Year Outlook Remains Unchanged

THOMSON REUTERS
·
01 May

Warrior Reports First Quarter 2025 Results

Business Wire
·
01 May

Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware

Business Wire
·
29 Apr

KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Business Wire
·
28 Apr

Warrior Met Coal (NYSE:HCC) Is Due To Pay A Dividend Of $0.08

Simply Wall St.
·
27 Apr

Agenus’ BOT/BAL Data in Pretreated Liver Cancer Presented at AACR 2025

Business Wire
·
26 Apr

Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer

PR Newswire
·
25 Apr

Earnings Preview: Peabody Energy (BTU) Q1 Earnings Expected to Decline

Zacks
·
24 Apr

Bristol Myers Squibb Reports First Quarter Financial Results for 2025

Business Wire
·
24 Apr

Warrior Met Coal Keeps Quarterly Dividend at $0.08/Share, Payable May 12 to Holders of Record May 5

MT Newswires Live
·
24 Apr